Periscope Capital’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Periscope Capital’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-37,000	Closed	-$3K	–	1187
2022 Q2	$3K	Hold	37,000	–	–	﹤0.01%	1153
2022 Q1	$7K	Hold	37,000	–	–	﹤0.01%	1150
2021 Q4	$22K	Hold	37,000	–	–	﹤0.01%	957
2021 Q3	$24K	Hold	37,000	–	–	﹤0.01%	867
2021 Q2	$41K	Hold	37,000	–	–	﹤0.01%	729
2021 Q1	$34K	Buy	+37,000	New	+$62.6K	﹤0.01%	553

Other funds holding FLACW

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Periscope Capital's FLACW Position: Q3 2022 in Review

Periscope Capital sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q3 2022, closing a stake of 37,000 shares — an estimated $3K sold.

Periscope Capital first reported a position in FLACW in Q1 2021 and held it in 6 quarters. The position peaked at $41K in Q2 2021. 21 funds tracked by Wall St. Rank hold FLACW as of Q3 2022.

Periscope Capital reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
Periscope Capital sold 37,000 Frazier Lifesciences Acquisition Corporation Warrant shares in Q3 2022, an estimated $3K.
Periscope Capital first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 6 quarters.
Periscope Capital's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $41K in Q2 2021.
21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q3 2022.

Based on Periscope Capital's 13F filing for Q3 2022, filed 8 Nov 2022.